director of the Interventional Therapy department
chief physician, Master of medicine
He resigned as director of Jilin People's Hospital and joined the Guowen Medical corporation Changchun hospital.
He has been engaged in interventional oncology for 25 years. Regional targeted therapy for primary liver cancer and metastatic liver cancer, interventional therapy for digestive tract tumors/liver metastases/lung cancer/pelvic tumors/obstructive jaundice/tumor complications, and image-guided percutaneous particle implantation for solid tumors were carried out simultaneously at the Department of Interventional Therapy, Peking University Cancer Hospital. Continuous infusion chemotherapy is a breakthrough in the treatment of liver metastases by delivering targeted regional infusion chemotherapy/thrombec-based therapy in the hepatic artery or portal vein (embedded pump).
Tumor intervention: malignant tumors such as liver cancer, lung cancer, pancreatic cancer, esophageal cancer, gastric cancer, intestinal cancer, intestinal obstruction, cervical cancer, bladder cancer; benign tumors such as hepatic hemangioma, uterine fibroids, adenomyosis; transcatheter arterial perfusion with drugs and embolization. Local radiofrequency or microwave ablation or cryoablation. Local iodine 125 radioactive particle implantation is also available.
Emergency interventions: hemoptysis, gastrointestinal bleeding, urinary bleeding, hepatocellular carcinoma rupture bleeding, hepatic and splenic trauma bleeding, postpartum hemorrhage, post-surgical bleeding interventions to stop bleeding.
